Expected earnings - NurExone Biologic Inc.
Source: Canadian Earnings Reports
NurExone Biologic Inc. (NRX:CA) is expected to report $-0.03 for Q2 2025
NurExone Biologic Inc.
NASDAQ: NRX:CC
NRX:CC Trading
G/L:
$ Last:
0 Volume:
$ Open:
NRX:CC Latest News
February 27, 2026 04:03:00 pm
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
February 10, 2026 04:03:00 pm
NurExone Biologic Advances Manufacturing and Regulatory Roadmap with Independent Batch Consistency Results for Exosome Production
January 30, 2026 04:03:00 pm
NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise
